Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bullous systemic lupus erythematosus.
Sebaratnam DF, Murrell DF. Sebaratnam DF, et al. Dermatol Clin. 2011 Oct;29(4):649-53. doi: 10.1016/j.det.2011.06.002. Epub 2011 Aug 3. Dermatol Clin. 2011. PMID: 21925012
Quality of life in patients with bullous dermatoses.
Sebaratnam DF, McMillan JR, Werth VP, Murrell DF. Sebaratnam DF, et al. Clin Dermatol. 2012 Jan-Feb;30(1):103-7. doi: 10.1016/j.clindermatol.2011.03.016. Clin Dermatol. 2012. PMID: 22137233 Free PMC article. Review.
Quality-of-life measurement in blistering diseases.
Sebaratnam DF, Frew JW, Davatchi F, Murrell DF. Sebaratnam DF, et al. Dermatol Clin. 2012 Apr;30(2):301-7, ix. doi: 10.1016/j.det.2011.11.008. Epub 2011 Dec 20. Dermatol Clin. 2012. PMID: 22284144 Review.
Diffuse melanosis cutis: a systematic review of the literature.
Sebaratnam DF, Venugopal SS, Frew JW, McMillan JR, Finkelstein ER, Martin LK, Murrell DF. Sebaratnam DF, et al. J Am Acad Dermatol. 2013 Mar;68(3):482-8. doi: 10.1016/j.jaad.2012.08.018. Epub 2012 Dec 6. J Am Acad Dermatol. 2013. PMID: 23219556 Review.
The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.
Tjokrowidjaja A, Daniel BS, Frew JW, Sebaratnam DF, Hanna AM, Chee S, Dermawan A, Wang CQ, Lim C, Venugopal SS, Rhodes LM, Welsh B, Nijsten T, Murrell DF. Tjokrowidjaja A, et al. Among authors: sebaratnam df. Br J Dermatol. 2013 Nov;169(5):1000-6. doi: 10.1111/bjd.12623. Br J Dermatol. 2013. PMID: 24102329
120 results